Contact Us | 1-877-576-3636

Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

PAS Webinar: RNAscope™ ISH Services for Biomarker Assay Development

Pellentesque non magna eget ex lobortis finibus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam nec arcu non eros hendrerit viverra a vitae libero. Etiam et ultricies nulla. Donec euismod lectus magna, eu dignissim mauris hendrerit vulputate.

PAS Webinar: RNAscope™ ISH Services for Biomarker Assay Development

Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

PAS Webinar: RNAscope™ ISH Services for Biomarker Assay Development

February 11, 2021 @ 10am PST | 1pm EST | 7pm CEST

This webinar will provide an overview of how Bio-Techne’s Assay Services’ Team expertise in RNAscope technology is being utilized by Biopharma for the development of biomarkers and companion diagnostic assays to support their therapeutic programs. Advanced Cell Diagnostics’ RNAscope in situ hybridization (ISH) platforms are widely utilized for high resolution tissue-based and cell-specific analysis of targets and biomarkers.

The RNAscope ISH platform is clinically validated and enables quantitative expression analysis that has repeatedly been proven to better stratify treatment-responsive and non-responsive patients in therapeutic clinical trials compared to traditional methods such as IHC and qPCR. RNAscope is often more sensitive than IHC and provides cell-specific biomarker data in complex tissue microenvironments that qPCR cannot.


LEARNING OBJECTIVES

  • Biomarker validation to accelerate translation of assays into clinical development in a GCLP setting in a matter of 4-6 weeks*
  • Assay feasibility and development - sensitivity, specificity, and precision testing (repeatability & reproducibility)

  • Development of pathologist scoring and HALO™ image analysis algorithms for biomarker assessment.

  • Established protocols for clinical assay transfer to CLIA-certified labs for prospective use.

  • RNAscope multiplexing and validated protocols for co-detection of biomarkers and immune cell markers

  • Quantifiable, cell-specific, single-molecule detection of RNA biomarkers in tumor biopsies

  • Superior performance against traditional methods, e.g., IHC, qPCR

  • Application in small molecule, biologic, and cell therapy biomarkers


SPEAKERS

ElizabethKim.jpg

Elizabeth Kim
Research Associate, Pharma Assay Services
Advanced Cell Diagnostics, a Bio-Techne brand

ChristianReyes.jpg

Christian Reyes
Team Lead, Pharma Assay Services
Advanced Cell Diagnostics, a Bio-Techne brand

Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.